Colabufo Nicola A, Berardi Francesco, Contino Marialessandra, Niso Mauro, Perrone Roberto
Dipartimento Farmacochimico, Università degli Studi di Bari, Bari, Italy.
Curr Top Med Chem. 2009;9(2):119-29. doi: 10.2174/156802609787521553.
Pharmacokinetic limitations affect drug bioavailability determining the loss or the reduction of the pharmacological effects. The Gastro Intestinal tract (GI) and the Blood Brain Barrier (BBB) are the most important restrictive and selective physiological lines of defense of the organism. Although several parameters such as LogP, LogD and K(a) have been extensively employed for determining drug bioavailability, the active transports, present in these biological barriers, play an important role for dosing and limiting cell drugs concentration. In particular, ATP Binding Cassette (ABC) transporters are involved in the active transport both in GI and BBB. Their strategic activity and biochemical and pharmacological role are herein treated.
药代动力学限制会影响药物的生物利用度,从而决定药理作用的丧失或减弱。胃肠道(GI)和血脑屏障(BBB)是机体最重要的限制性和选择性生理防线。尽管诸如LogP、LogD和K(a)等几个参数已被广泛用于确定药物的生物利用度,但这些生物屏障中存在的主动转运对给药和限制细胞内药物浓度起着重要作用。特别是,ATP结合盒(ABC)转运蛋白参与了胃肠道和血脑屏障中的主动转运。本文将探讨它们的战略活性以及生化和药理作用。